Target intelligence / Profile preview

Phosphofurin acidic cluster sorting protein 1 (PACS1)

Target
PACS1
Molecular classification
Other (sorting/adaptor protein)
01

Overview

Phosphofurin acidic cluster sorting protein 1 (PACS1) is a cytosolic coat protein essential for the sorting and localization of membrane proteins, particularly within the trans-Golgi network (TGN)[1][4]. PACS1 interacts with proteins containing phosphorylated acidic cluster motifs, facilitating their endosomal-to-Golgi trafficking and retrieval of specific molecules such as furin and the mannose-6-phosphate receptor[1][4]. It is also involved in moving HIV-1 Nef-mediated MHC-I molecules away from the cell surface to the TGN, contributing to immune evasion by the virus[1]. Recent research highlights PACS1’s roles in the nucleus, where it participates in DNA replication repair, viral RNA export, chromatin stability via histone deacetylase interactions, and RNA binding[2]. PACS1 is necessary for normal lymphocyte development, ER calcium handling in immune cells, and neural development, with expression highest during embryonic brain formation and maintained at lower levels in adulthood[2]. Pathogenic PACS1 variants, particularly the recurrent p.R203W substitution, result in PACS1 syndrome (Schuurs-Hoeijmakers syndrome), which is marked by intellectual disability, craniofacial abnormalities, epilepsy, and developmental delay[2]. No drugs directly target PACS1, nor is it classified as a typical therapeutic target like a receptor, enzyme, or transporter[1][2].

Other names
KIAA1175PACS-1FLJ10209MRD17SHMScytosolic sorting protein PACS-1
02

Biological functions

Protein sorting in the trans-Golgi networkEndosome-to-Golgi traffickingRetrieval of membrane proteins (e.g., furin, mannose-6-phosphate receptor)Regulation of immune surveillance via MHC-I traffickingDNA replication repairChromatin regulation via histone deacetylase bindingLymphocyte development and survival
03

Disease associations

PACS1 syndrome (Schuurs-Hoeijmakers syndrome)Developmental delayNeurodevelopmental disordersEpilepsyAutism spectrum disorderCardiac disordersPsychiatric disorders (bipolar disorder, obesity association via GWAS)
04

Safety considerations

Pathogenic variants cause neurodevelopmental disorders with distinct craniofacial and neurological features[2].No current targeted therapies; loss/gain-of-function effects under investigation[2].

Beyond the preview

Go deeper on Phosphofurin acidic cluster sorting protein 1 (PACS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphofurin acidic cluster sorting protein 1 (PACS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call